Chawla S, Hill A, Fearfield L, Johnston S, et al. Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience. Breast Cancer Res Treat 2021 Mar 8. pii: 10.1007/s10549-021-06169.
PMID: 33683521